Sie suchten nach: cvp (Englisch - Dänisch)

in combination with cvp chemotherapyin follicular lymphoma
kombination med cvp-kemoterapi ved follikulært lymfom

general vice-chairman, cvp (1996- ).
næstformand i cvp (siden 1996).

41 in combination with cvp chemotherapy in follicular lymphoma
kombination med cvp kemoterapi ved follikulært lymfom

0 chairman of the young cvp (1967-1971).
0 formand for cvp's ungdomsafdeling (1967-1971). formand for cvp (1972-1979).

in severe cases, ecg and cvp should be followed.
i alvorlige tilfælde skal ekg og cvp følges.

0 member of the cvp party bureau (1989-1992).
Φ medlem af cvp's partipræsidium (1989­1992).

o member of the cvp national executive; municipal coundltor at herent.
o medlem af cvp's forretningsudvalg. medlem af kommunalbestyrelsen i herent.

g member of the cvp national bureau 1968-1984 and of the national party executive since 1968.
dr. jur. g medlem af c.v.p.s forretningsudvalg 1968-1984 og af hovedbestyrelsen siden 1968.

22.11.1942 member of the european parliament belgium cvp mep: 17.12.1981 ppe
22.11.1942 medlem af europa-parlamentet belgien cvp mep: 17.12.1981

mabthera is indicated for the treatment of previously untreated patients with stage iii-iv follicular lymphoma in combination with cvp chemotherapy.
dato for udstedelse af markedsføringstilladelsen gyldig i hele den europæiske union:

53 33.6 80.9 r-cvp, 162 81 41 p < 0.0001 p=0.029
14. 7 80. 9 33. 6 p=0. 029 p < 0. 0001

r-cvp led to a significant benefit over cvp for the primary endpoint, time to treatment failure (27 months vs.
r-cvp var signifikant bedre end cvp mht. det primære endepunkt, tid til behandlingssvigt (27 måneder versus 6,6 måneder), p < 0,0001,log rank test).

the proportion of patients with a tumour response (cr, cru, pr) was significantly higher (p< 0.0001 chi-square test) in the r-cvp group (80.9 %) than the cvp group (57.2 %).
andelen af patienter med tumorrespons (cr, cru, pr) var signifikant højere (p < 0,0001 chi square test) i r-cvp-gruppen (80,9 %) end i cvp-gruppen (57,2 %).